Drugs / Cvac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01617629 | Dec 2011 → Apr 2014 | malignant epithelial tumor of ovary | Prima BioMed Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cvac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01617629 ↗ |
| Modality | Vaccine | “MUC1 Dendritic Cell Vaccine (Cvac)” NCT01617629 ↗ |